Novartis Ag (NVS) Cash & Equivalents (2009 - 2026)
Novartis Ag (NVS) recorded Cash & Equivalents of $7.62 billion in Q2 2026, up 14.4% from $6.66 billion a year earlier and up 10.7% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag reported Cash & Equivalents of $11.44 billion, down 0.2% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $11.46 billion in FY2024 (-14.4%), $13.39 billion in FY2023 (+78.2%), $7.52 billion in FY2022 (-39.4%) and $12.41 billion in FY2021 (+28.5%).
- Quarterly Cash & Equivalents has ranged from $3.63 billion in Q2 2022 to $13.85 billion in Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in two of the last eight quarters, with an average decline of 8.0%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 264.4% in Q1 2022, against a decline of 39.4% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.88 billion (Q1 2026), $11.44 billion (Q4 2025) and $9.56 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 6.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.62 Bn |
| Mar 31, 2026 | 6.88 Bn |
| Dec 31, 2025 | 11.44 Bn |
| Sep 30, 2025 | 9.56 Bn |
| Jun 30, 2025 | 6.66 Bn |
| Mar 31, 2025 | 7.07 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 30, 2024 | 13.61 Bn |
| Jun 30, 2024 | 7.90 Bn |
| Mar 31, 2024 | 9.47 Bn |
| Dec 31, 2023 | 13.39 Bn |
| Sep 30, 2023 | 12.41 Bn |
| Jun 30, 2023 | 10.89 Bn |
| Mar 31, 2023 | 12.00 Bn |
| Dec 31, 2022 | 7.52 Bn |
| Sep 30, 2022 | 8.73 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Mar 31, 2022 | 13.85 Bn |
| Dec 31, 2021 | 12.41 Bn |
| Sep 30, 2021 | 7.21 Bn |
API Access
Novartis Ag Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();